Shining the Light on a Combination Products Platform

Light Sciences is using a spin-off strategy to revive light-activated therapy in a number of clinical areas, trasnforming a niche application into a platform technology.

By Stephen Levin

The recent growth of combination drug-device products arises not only from made-from-scratch new technologies, such as orthobiologic materials and drug-eluting...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Innovation

More from In Vivo